학술논문
Allosteric SHP2 inhibitor, IACS-13909, overcomes EGFR-dependent and EGFR-independent resistance mechanisms toward osimertinib
Document Type
Article
Author
Sun, Y.; Meyers, B.A.; Harris, A.L.; Johnson, S.; Bivona, B.J.; Bristow, C.A.; Carrillo, C.C.; Chang, Q.; Feng, N.; Gao, G.; Gera, S.; Giuliani, V.; Huang, J.K.; Kovacs, J.J.; Liu, C.-Y.; Lopez, A.M.; Ma, X.; Miller, M.A.; Mullinax, R.A.; Peoples, M.; Ramamoorthy, V.; Seth, S.; Spencer, N.D.; Suzuki, E.; Zuniga, A.M.; Marszalek, J.R.; Heffernan, T.P.; Czako, B.; Leonard, P.; Mseeh, F.; Wu, Q.; Parker, C.A.; Cross, J.B.; Di Francesco, M.E.; Burke, J.P.; Carroll, C.L.; Jiang, Y.; Kang, Z.; Mandal, P.K.; McAfoos, T.; Williams, C.C.; Yu, S.S.; Jones, P.; Draetta, G.F.; Kohl, N.E.
Source
In: Cancer Research . (Cancer Research, 1 November 2020, 80(21):4840-4853)
Subject
Language
English
ISSN
15387445
00085472
00085472